| Title : Inhibitors of soluble epoxide hydrolase on acute lung injury: a meta-analysis of preclinical studies - Tao_2022_Inflammopharmacology__ |
| Author(s) : Tao W , Xu G , Luo Y , Li PS |
| Ref : Inflammopharmacology , : , 2022 |
|
Abstract :
INTRODUCTION: This study investigated the effects of soluble epoxide hydrolase (sEH) inhibitors on acute lung injury (ALI) using the measure of meta-analysis. METHODS: Relative publications were systematic reviewed and retrieved by searching electronic databases including the Cochrane Library, PubMed, China National Knowledge Infrastructure, Wanfang Data, and Google Scholar. RESULTS: Seven animal studies were included in this meta-analysis. Our result showed that the lung injury scores (SMD = - 2.31, 95% CI - 3.50 to - 1.12) and lung wet to dry weight ratios (WMD-1.44, 95% CI - 1.69 to - 1.18) were reduced in sEH inhibitors-treated animals compared with control. The mortality was improved by sEH inhibitors at 48 h (RR = 0.62, 95% CI 0.42 to 0.92), 72 h, and 120 h, but not at 24 h (RR = 0.59, 95% CI 0.35 to 1.01) and 96 h, after induction of ALI model. CONCLUSIONS: The sEH inhibitor is a potent candidate of pharmacological agents for ALI/acute respiratory distress syndrome, as its effects on improvement of lung injury and mortality in preclinical researches. |
| PubMedSearch : Tao_2022_Inflammopharmacology__ |
| PubMedID: 36085400 |
Tao W, Xu G, Luo Y, Li PS (2022)
Inhibitors of soluble epoxide hydrolase on acute lung injury: a meta-analysis of preclinical studies
Inflammopharmacology
:
Tao W, Xu G, Luo Y, Li PS (2022)
Inflammopharmacology
: